David Willman is a former investigative reporter for the Los Angeles Times. Willman won the Pulitzer Prize for investigative reporting for articles that prompted the market withdrawal of Rezulin, a widely sold diabetes drug. His subsequent reports, documenting widespread pharmaceutical industry payments to federal researchers, triggered a ban of such compensation at the U.S. National Institutes of Health. His work has also exposed the nation’s unreliable system for countering bioterrorism. He is author of “The Mirage Man,” the groundbreaking account of the anthrax letter attacks. Willman’s national honors include the top award from Investigative Reporters and Editors (twice), the Worth Bingham Prize for Investigative Journalism, the Scripps Howard Foundation’s award for best Washington-based reporting and, with colleagues, the George Polk Award.
Latest From This Author
Los reguladores han hecho caso omiso de las advertencias para detener el otorgamiento de licencias de dispositivos que contienen cesio radiactivo
Regulators have disregarded warnings to stop licensing devices containing radioactive cesium. Hundreds are in use, and the risk has grown, an L.A. Times investigation has found.
BioDetection 21, the subject of a Times investigation, “should not move forward until fundamental concerns ... are resolved,” congresswoman says.
Cómo las empresas ayudaron a reescribir una ley para dificultar que los médicos forenses les impidieran cosechar partes del cuerpo
How firms helped rewrite a law to make it difficult for coroners to stop them from harvesting body parts.
James F. McDonnell’s resignation comes at the request of Acting Homeland Security Secretary Kevin McAleenan and would become effective Thursday.
In a three-page letter, congressional officials respond to an L.A. Times investigation by pressing Trump administration for documents, private meeting.
The Trump administration’s attempt to deploy a scientifically disputed system for detecting airborne anthrax or other infectious agents in terrorist attacks is facing increased scrutiny from a bipartisan group of House members.
Critics say the Trump administration’s cuts in counterterrorism programs put the nation at risk.
El Departamento de Seguridad Nacional ha desmantelado o puesto fin a múltiples programas destinados a contrarrestar los ataques con armas de destrucción masiva, encontró una investigación del Times.